These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 10220483)
1. Effect of selected antimalarial drugs and inhibitors of cytochrome P-450 3A4 on halofantrine metabolism by human liver microsomes. Baune B; Furlan V; Taburet AM; Farinotti R Drug Metab Dispos; 1999 May; 27(5):565-8. PubMed ID: 10220483 [TBL] [Abstract][Full Text] [Related]
2. Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5. Baune B; Flinois JP; Furlan V; Gimenez F; Taburet AM; Becquemont L; Farinotti R J Pharm Pharmacol; 1999 Apr; 51(4):419-26. PubMed ID: 10385214 [TBL] [Abstract][Full Text] [Related]
3. In vitro antimalarial interactions between mefloquine and cytochrome P450 inhibitors. Wisedpanichkij R; Chaijaroenkul W; Sangsuwan P; Tantisawat J; Boonprasert K; Na-Bangchang K Acta Trop; 2009 Oct; 112(1):12-5. PubMed ID: 19497287 [TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 3A4 in vivo ketoconazole competitive inhibition: determination of Ki and dangers associated with high clearance drugs in general. Boxenbaum H J Pharm Pharm Sci; 1999; 2(2):47-52. PubMed ID: 10952769 [TBL] [Abstract][Full Text] [Related]
5. Primaquine metabolism by human liver microsomes: effect of other antimalarial drugs. Bangchang KN; Karbwang J; Back DJ Biochem Pharmacol; 1992 Aug; 44(3):587-90. PubMed ID: 1510705 [TBL] [Abstract][Full Text] [Related]
6. An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems. Halliday RC; Jones BC; Smith DA; Kitteringham NR; Park BK Br J Clin Pharmacol; 1995 Oct; 40(4):369-78. PubMed ID: 8554939 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of tolbutamide metabolism by antimalarial drugs. Karbwang J; Back DJ; Bunnag D; Breckenridge AM Southeast Asian J Trop Med Public Health; 1988 Jun; 19(2):235-41. PubMed ID: 3227403 [TBL] [Abstract][Full Text] [Related]
8. Metabolic interactions of selected antimalarial and non-antimalarial drugs with the major pathway (3-hydroxylation) of quinine in human liver microsomes. Zhao XJ; Ishizaki T Br J Clin Pharmacol; 1997 Nov; 44(5):505-11. PubMed ID: 9384469 [TBL] [Abstract][Full Text] [Related]
9. Mefloquine metabolism by human liver microsomes. Effect of other antimalarial drugs. Bangchang KN; Karbwang J; Back DJ Biochem Pharmacol; 1992 May; 43(9):1957-61. PubMed ID: 1596283 [TBL] [Abstract][Full Text] [Related]
10. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A. Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860 [TBL] [Abstract][Full Text] [Related]
11. The stereoselective metabolism of halofantrine to desbutylhalofantrine in the rat: evidence of tissue-specific enantioselectivity in microsomal metabolism. Gharavi N; Sattari S; Shayeganpour A; El-Kadi AO; Brocks DR Chirality; 2007 Jan; 19(1):22-33. PubMed ID: 17089336 [TBL] [Abstract][Full Text] [Related]
12. Interaction of diclofenac and quinidine in monkeys: stimulation of diclofenac metabolism. Tang W; Stearns RA; Kwei GY; Iliff SA; Miller RR; Egan MA; Yu NX; Dean DC; Kumar S; Shou M; Lin JH; Baillie TA J Pharmacol Exp Ther; 1999 Dec; 291(3):1068-74. PubMed ID: 10565826 [TBL] [Abstract][Full Text] [Related]
13. Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole. von Moltke LL; Greenblatt DJ; Harmatz JS; Duan SX; Harrel LM; Cotreau-Bibbo MM; Pritchard GA; Wright CE; Shader RI J Pharmacol Exp Ther; 1996 Feb; 276(2):370-9. PubMed ID: 8632299 [TBL] [Abstract][Full Text] [Related]
14. An inhibition study of beauvericin on human and rat cytochrome P450 enzymes and its pharmacokinetics in rats. Mei L; Zhang L; Dai R J Enzyme Inhib Med Chem; 2009 Jun; 24(3):753-62. PubMed ID: 18956271 [TBL] [Abstract][Full Text] [Related]
15. Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes. Cherstniakova SA; Bi D; Fuller DR; Mojsiak JZ; Collins JM; Cantilena LR Drug Metab Dispos; 2001 Sep; 29(9):1216-20. PubMed ID: 11502731 [TBL] [Abstract][Full Text] [Related]
16. Effects of selective cytochrome P-450 inhibitors on the metabolism of thioridazine. In vitro studies. Daniel WA; Syrek M; Haduch A Pol J Pharmacol; 1999; 51(5):435-42. PubMed ID: 10817545 [TBL] [Abstract][Full Text] [Related]
17. FK 506 (Tacrolimus) metabolism by rat liver microsomes and its inhibition by other drugs. Prasad TN; Stiff DD; Subbotina N; Zemaitis MA; Burckart GJ; Starzl TE; Venkataramanan R Res Commun Chem Pathol Pharmacol; 1994 Apr; 84(1):35-46. PubMed ID: 7518966 [TBL] [Abstract][Full Text] [Related]
18. Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone. Kitamura A; Mizuno Y; Natsui K; Yabuki M; Komuro S; Kanamaru H Biopharm Drug Dispos; 2005 Mar; 26(2):59-65. PubMed ID: 15619261 [TBL] [Abstract][Full Text] [Related]
19. Ketoconazole potentiates terfenadine-induced apoptosis in human Hep G2 cells through inhibition of cytochrome p450 3A4 activity. Wang YJ; Yu CF; Chen LC; Chen CH; Lin JK; Liang YC; Lin CH; Lin SY; Chen CF; Ho YS J Cell Biochem; 2002; 87(2):147-59. PubMed ID: 12244568 [TBL] [Abstract][Full Text] [Related]
20. Metabolism and metabolic inhibition of cilnidipine in human liver microsomes. Liu XQ; Zhao Y; Li D; Qian ZY; Wang GJ Acta Pharmacol Sin; 2003 Mar; 24(3):263-8. PubMed ID: 12617777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]